latest news releases from the newsroom
XsunX Extends Marketing Presence With Addition of MarComm Manager
ALISO VIEJO, Calif., Sept. 21, 2006 (PRIMEZONE) -- XsunX, Inc. (OTCBB:XSNX), provider of technologies for solar energy infrastructure and developer of Power Glass(tm), an innovative thin-film solar technology that is intended to allow glass windows to produce electricity from the power of the sun, today announces the appointment of Ms. Holly Jocoy to the position of MarComm Manager. In her new position Ms. Jocoy will focus on Marketing Communication at both national and international levels.
QLogic Receives Distribution Industry's Rising Star Award
ALISO VIEJO, Calif., Sept. 21, 2006 (PRIMEZONE) -- QLogic(r) Corp. (Nasdaq:QLGC), the leader in Fibre Channel host bus adapters (HBAs), stackable switches and blade server switches, today announced that it is a recipient of the Global Technology Distribution Council's inaugural Rising Star Award for outstanding sales growth through IT distributors. The GTDC presented the award to David Zimmer, senior director Worldwide Channels, at its annual Summit event, held this year at San Francisco's Fairmont Hotel, Sept. 19-20, and attended by the world's leading IT vendors and distributors.
Parker Waichman Alonso LLP
Parker & Waichman, LLP Believes New Study On Ortho Evra Provides Further Evidence That the Birth Control Patch is Associated With Higher Rates of Blood Clots
NEW YORK, Sept. 21, 2006 (PRIMEZONE) -- Parker & Waichman, LLP (www.yourlawyer.com) announced that it believes a new study provides further evidence that Ortho Evra is dangerous and should be recalled from the market. The study found that women using the Ortho Evra birth control patch were twice as likely to develop blood clots compared with those using oral birth control pills. Parker & Waichman, LLP currently represents hundreds of clients who were injured while using the Ortho Evra birth control patch. The firm has cases pending in state and federal courts against Ortho-McNeil Pharmaceutical, Inc, a division of Johnson & Johnson, Inc. (NYSE:JNJ). For more information on Ortho Evra, please visit www.orthopatchlawsuit.com and www.yourlawyer.com/topics/overview/Ortho_Evra_Patch.
Oakley Announces Transition of Chief Operating Officer to Senior Strategic Advisory Role
FOOTHILL RANCH, Calif., Sept. 21, 2006 (PRIMEZONE) -- Oakley, Inc. (NYSE:OO) today announced that Link Newcomb has resigned as Chief Operating Officer and from the company's Board of Directors, and will transition to the newly created role of Senior Advisor to the Chief Executive Officer. Mr. Newcomb joined Oakley in June 1994 as vice president of international sales and has served in a number of different capacities over his 12-year tenure, including chief operating officer since 1999.